These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20805263)

  • 1. Fatigue in hemodialysis patients with and without diabetes: results from a randomized controlled trial of two glucose-containing dialysates.
    Raimann JG; Kruse A; Thijssen S; Kuntsevich V; Diaz-Buxo JA; Levin NW; Kotanko P
    Diabetes Care; 2010 Sep; 33(9):e121. PubMed ID: 20805263
    [No Abstract]   [Full Text] [Related]  

  • 2. Icodextrin - still a cause for concern with blood glucose monitoring in continuous ambulatory peritoneal dialysis patients with diabetes.
    Slim S; Griffiths MJ; Gama R
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):196-7. PubMed ID: 17362588
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing diabetes in hemodialysis patients: observations and recommendations.
    Shrishrimal K; Hart P; Michota F
    Cleve Clin J Med; 2009 Nov; 76(11):649-55. PubMed ID: 19884294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-charged dialysate for children on hemodialysis: acute dialytic changes.
    Fischbach M; Terzic J; Bitoun Cohen C; Cousandier E; Hamel G; Battouche D; Geisert J
    Pediatr Nephrol; 1998 Jan; 12(1):60-2. PubMed ID: 9502570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of clinical trial experience with icodextrin.
    Wolfson M; Ogrinc F; Mujais S
    Kidney Int Suppl; 2002 Oct; (81):S46-52. PubMed ID: 12230481
    [No Abstract]   [Full Text] [Related]  

  • 6. Biocompatibility of icodextrin.
    Cooker LA; Holmes CJ; Hoff CM
    Kidney Int Suppl; 2002 Oct; (81):S34-45. PubMed ID: 12230480
    [No Abstract]   [Full Text] [Related]  

  • 7. How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient's Health).
    Bonomini M; Masola V; Procino G; Zammit V; Divino-Filho JC; Arduini A; Gambaro G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic reactions to icodextrin in patients with renal failure.
    Divino Fiho JC
    Lancet; 2000 Apr; 355(9212):1364-5. PubMed ID: 10776767
    [No Abstract]   [Full Text] [Related]  

  • 9. Icodextrin: an alternative peritoneal dialysis fluid.
    Chhabra D; Nash K
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients.
    Cho Y; Johnson DW; Badve SV; Craig JC; Strippoli GF; Wiggins KJ
    Kidney Int; 2013 Nov; 84(5):969-79. PubMed ID: 23698236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and laboratory effects of icodextrin.
    Gokal R; Moberly J; Lindholm B; Mujais S
    Kidney Int Suppl; 2002 Oct; (81):S62-71. PubMed ID: 12230483
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Dialysate Glucose Concentration on Hepcidin Clearance in Maintenance Hemodialysis Patients.
    Zou LX; Sun L; Deng N; Sun L; Han YC
    Iran J Kidney Dis; 2019 Mar; 13(2):113-119. PubMed ID: 30988248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dialysate on gastric emptying time in peritoneal dialysis patients.
    Van V; Schoonjans RS; Struijk DG; Verbanck JJ; Vanholder RC; Van B; Lefebvre RA; De V; Lameire NH
    Perit Dial Int; 2002; 22(1):32-8. PubMed ID: 11929141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A spoonful of sugar.
    Topley N
    Nephron Clin Pract; 2003; 93(3):c83-4. PubMed ID: 12660415
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial.
    Raimann JG; Kruse A; Thijssen S; Kuntsevich V; Dabel P; Bachar M; Diaz-Buxo JA; Levin NW; Kotanko P
    Nephrol Dial Transplant; 2012 Apr; 27(4):1559-68. PubMed ID: 21940484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible peritoneal dialysis solutions: do we have one?
    Chaudhary K; Khanna R
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between standard single chamber versus dual chamber low glucose degradation product peritoneal dialysis fluids.
    Vareesangthip K; Vongsanim S; Fan S; Davenport A
    Artif Organs; 2021 Jan; 45(1):88-94. PubMed ID: 32645750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysate calcium use in hemodialysis patients.
    Backenroth R
    Kidney Int; 2003 Oct; 64(4):1533. PubMed ID: 12969180
    [No Abstract]   [Full Text] [Related]  

  • 20. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.